Zarei, M., Giannikou, K., Du, H., Liu, H., Duarte, M., Johnson, S., . . . Kwiatkowski, D. J. (2020). MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61. Oncogene.
シカゴスタイル引用形Zarei, Mahsa, et al. "MITF Is a Driver Oncogene and Potential Therapeutic Target in Kidney Angiomyolipoma Tumors Through Transcriptional Regulation of CYR61." Oncogene 2020.
MLA引用形式Zarei, Mahsa, et al. "MITF Is a Driver Oncogene and Potential Therapeutic Target in Kidney Angiomyolipoma Tumors Through Transcriptional Regulation of CYR61." Oncogene 2020.
警告: この引用は必ずしも正確ではありません.